These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 32157424)

  • 1. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria.
    Yin J; Meng Q; Cheng D; Fu J; Luo Q; Liu Y; Yu Z
    Appl Microbiol Biotechnol; 2020 May; 104(9):3771-3780. PubMed ID: 32157424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Polymyxin Resistance.
    Moffatt JH; Harper M; Boyce JD
    Adv Exp Med Biol; 2019; 1145():55-71. PubMed ID: 31364071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.
    Mohapatra SS; Dwibedy SK; Padhy I
    J Biosci; 2021; 46(3):. PubMed ID: 34475315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Polymyxin by Hydrolytic Mechanism.
    Yin J; Wang G; Cheng D; Fu J; Qiu J; Yu Z
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
    Ezadi F; Ardebili A; Mirnejad R
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxins and their novel derivatives.
    Vaara M
    Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to polymyxins: Mechanisms, frequency and treatment options.
    Falagas ME; Rafailidis PI; Matthaiou DK
    Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
    Poirel L; Jayol A; Nordmann P
    Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
    Huang J; Zhu Y; Han ML; Li M; Song J; Velkov T; Li C; Li J
    Int J Antimicrob Agents; 2018 Apr; 51(4):586-593. PubMed ID: 29288722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the antibacterial activity of polymyxins using a nonantibiotic drug.
    Krishnamurthy M; Lemmon MM; Falcinelli EM; Sandy RA; Dootz JN; Mott TM; Rajamani S; Schaecher KE; Duplantier AJ; Panchal RG
    Infect Drug Resist; 2019; 12():1393-1405. PubMed ID: 31239720
    [No Abstract]   [Full Text] [Related]  

  • 16. AlmG, responsible for polymyxin resistance in pandemic
    Henderson JC; Herrera CM; Trent MS
    J Biol Chem; 2017 Dec; 292(51):21205-21215. PubMed ID: 29101229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents of Last Resort: An Update on Polymyxin Resistance.
    Yang Q; Pogue JM; Li Z; Nation RL; Kaye KS; Li J
    Infect Dis Clin North Am; 2020 Dec; 34(4):723-750. PubMed ID: 33011049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors.
    Llobet E; Campos MA; Giménez P; Moranta D; Bengoechea JA
    Infect Immun; 2011 Sep; 79(9):3718-32. PubMed ID: 21708987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin antibiotics for gram-negative infections.
    Arnold TM; Forrest GN; Messmer KJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
    Mlynarcik P; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.